Cita APA

Genovese, M. C., Glover, J., Greenwald, M., Porawska, W., El Khouri, E. C., Dokoupilova, E., . . . Alten, R. (2019). FKB327, an adalimumab biosimilar, versus the reference product: Results of a randomized, Phase III, double-blind study, and its open-label extension. Arthritis Res Ther.

Chicago Style Citation

Genovese, Mark C., et al. "FKB327, an Adalimumab Biosimilar, Versus the Reference Product: Results of a Randomized, Phase III, Double-blind Study, and Its Open-label Extension." Arthritis Res Ther 2019.

Cita MLA

Genovese, Mark C., et al. "FKB327, an Adalimumab Biosimilar, Versus the Reference Product: Results of a Randomized, Phase III, Double-blind Study, and Its Open-label Extension." Arthritis Res Ther 2019.